PolypDx™ receives patent approval in Europe

Metabolomic Technologies Inc. has been granted a patent for PolypDx™ by the European Patent Office. PolypDx™ received patent approval in Japan in September, 2015, and in Australia in February, 2017. Patents are also pending in the US, Canada and Hong Kong.